Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Enoxaparin for Postpartum Thromboprophylaxis After Cesarean Section
NCT07820670Recruiting
- Sponsor
- Edith Wolfson Medical Center
- Start
- Dec 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of rivaroxaban in venous thromboembolism (VTE) (2 arms), sponsored by Edith Wolfson Medical Center. Primary endpoint: Endogenous Thrombin Potential. Started Dec 2025; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT07820670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07820670.